This Article  • Full text  • PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (9)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Surgical Oncology  • Surgical Physiology, Other  • Gastrointestinal Diseases  • Genetics  • Genetic Counseling/ Testing/ Therapy  • Alert me on articles by topic

Nahid Hamoui, MD; Jeffrey H. Peters, MD; Sylke Schneider, MD; Kazumi Uchida, MD; Dongyun Yang, PhD; Daniel Valboehmer, MD; Jeffrey A. Hagen, MD; Steven R. DeMeester, MD; Tom R. DeMeester, MD; Kathleen Danenberg, BSc; Peter Danenberg, PhD

Arch Surg. 2004;139:712-716.

Hypothesis  Although genetic changes associated with the progression to Barrett esophagus and adenocarcinoma have been identified, changes in gene expression associated with gastroesophageal reflux disease have not been reported. We examined expression levels of several genes important in carcinogenesis and compared expression levels with alterations in esophageal acid exposure.

Patients, Design, and Setting  Prospective analysis of 61 patients initially seen with reflux symptoms at a private academic hospital.

Interventions  Paired esophageal biopsy specimens of squamous epithelium 3 cm above the squamocolumnar junction. All patients had 24-hour pH monitoring performed.

Main Outcome Measures  Cyclooxygenase (COX) 1, COX-2, thymidylate synthase, human telomerase reverse transcriptase (hTERT), Bcl-2 protein, survivin protein, secreted protein acidic and rich in cysteine (SPARC), tetraspan (TSPAN), and caudal-type homeobox transcription factor 2 (CDX2) messenger RNA expression analysis was performed on snap-frozen, microdissected tissue using a quantitative reverse transcriptase–polymerase chain reaction method. Linear regression and the Pearson product moment correlation were used to relate gene expression to parameters of the 24-hour pH record.

Results  Expression levels of COX-2 correlated positively with the 24-hour pH score (r = 0.25, P = .05). There was no correlation between the expression of other tested genes and esophageal acid exposure. There was also no significant increase in COX-2 expression in patients with esophagitis or in those who used nonsteroidal anti-inflammatory drugs.

Conclusions  To our knowledge, these data provide among the first reported correlation of genetic changes and increased esophageal acid exposure in patients with gastroesophageal reflux symptoms. The changes in gene expression occur before any metaplastic changes in the tissue are apparent, and may in the future be useful in predicting which patients will progress through a metaplasia-dysplasia carcinoma sequence.

From the Department of Surgery, Division of Thoracic and Foregut Surgery, University of Southern California, Los Angeles.

RELATED ARTICLE

This Month in Archives of Surgery
Arch Surg. 2004;139(7):705.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nonsteroidal Anti-inflammatory Drugs and Risk of Esophageal and Gastric Adenocarcinomas in Los Angeles County
Duan et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:126-134.
ABSTRACT | FULL TEXT  

Nonsteroidal Anti-inflammatory Drugs and the Esophageal Inflammation-Metaplasia-Adenocarcinoma Sequence.
Anderson et al.
Cancer Res. 2006;66:4975-4982.
ABSTRACT | FULL TEXT  

Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis
Hayakawa et al.
Gut 2006;55:450-456.
ABSTRACT | FULL TEXT